Cognitive dysfunction in idiopathic and vascular parkinsonism;Kognitivne promjene u osoba s idiopatskim i vaskularnim parkinsonizmom

Medicinski Glasnik

Volumn 8, Issue 2, 2011, Pages 209-215

  Bradvica, Ivanka Štenc ^a   Jančuljak, Davor ^a   Butković Soldo, Silva ^a   Vladetić, Mirjana ^a  

^a Department of Neurology   (Croatia)

Author keywords

Cognitive dysfunction; Mini mental state examination; Parkinsonism; Raven's progressive matrices

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGY; PARKINSON DISEASE; PARKINSONISM;

AGED; COGNITION DISORDERS; DEMENTIA; FEMALE; HUMANS; MALE; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; PSYCHOLOGICAL TESTS;

EID: 80051648369     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Owen AM. Cognitive dysfunction in Parkison's disease: the role of frontostriatal circuitry. Neuroscientist 2004; 10:525-37.
2. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G. Cognitive impairment in incident, untreated Parkinson's disease. Neurology 2009; 72:1121-6.
3. Samuel M, Maidment I, Boustani M, Fox Ch. Clinical managment of Parkinson's disease dementia: pitfalls and progress. Advances in Psychiatric Treatment 2006; 12:121-9
4. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000; 69: 308-12.
5. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P. Risk of dementia in Parkinson's disease. A community-based, prospective study. Neurology 2001; 56:730-6.
6. Braak H, Rub U, Braak E. Neuroanatomy of Parkinson's disease. Changes in the neuronal cyto skeleton of a few disease - suspectible types of neurons lead to progressive destruction of circumscribed areas in the limbic and motor systems. Nervenarzt 2000; 71:459-69
7. Agid Y. Parkinson's disease: Pathophysiology. Lancet 1991; 337:1321-4
8. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999; 56:98-102.
9. Yamanouchi H, Nagura H. Neurological signs and frontal white matter laesions in vascular parkinsonism - a clinicopathologic study. Stroke 1997; 28:965-9.
10. Reider-Groswasser I, Bornstein NM, Korzyn AD. Parkinsonism in patients with lacunar infarcts of the basal ganglia. Eur Neurol 1995; 35:46-9.
11. van Zagten M, Lodder J, Kessels F. Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter laesions. Mov disord 1998; 13:89-95.
12. Rampello L, Alvano A, Battaglia G, Raffaele R, Vecchio I, Malaguarnera M. Different clinical and evolutional patterns in late idiopathic and vascular arkinsonism. J Neurol. 2005; 252:1045-9.
13. Sibon I, Tison F. Vascular parkinsonism. Curr Opin Neurol 2004;17:49-54.
14. Rankin J. Cerebral vascular accidents in patients over the age of 60. Scott Med J 1957; 2:200-15.
15. Adams PH, Bendixen B, Kappelle J, Biller J, Love B, Gordon D, Marsh R. Classification of subtypes of acute ischemic stroke. Stroke 1993; 24: 35-41.
16. Ringelstein BE, Nabavi DG. Cerebral small vessel diseases: cerebral microangiopathies. Current Opinion in Neurology 2005; 18:179-88.
17. Hirsch EC. Biochemistry of Parkinson's disease with special reference to the dopaminergic system. Mol Neurobiol 2003; 9:135-42.
18. Folstein MF, Folstein SE. Mini Mental State. Journal of Psychiatric Research 1975; 12: 180-98.
19. Raven J, Raven JC, Court JH. Priručnik za Ravenove progresivne matrice i ljestvice rječnika 3. dio. Standardne progresivne matrice 1995; Naklada Slap, Jastrebarsko.
20. Matešić K, Matešić ml. K, Ružić V. Prilog Standardizaciji Ravenovih pregresivnih matrica SPM I SPM-T. U: Hadžiselimović Dž, Kolesarić V, Pregrad J, Plavšić M (ur). Psihologija-mediji-etika. Knjiga sažetaka 2008; str. 129-130, Poreč, Hrvatsko psihološko društvo-Društvo psihologa Istre.
21. Scigliano G, Musicco M, Soliveri P, Girroti F. Progression and prognosis in Parkinson's disease in relation to concomitant cerebral or peripheral vasculopathy. Advances in Neurology 1996; 69:305-9.
22. Katić S, Bašić J, Zarevski P, Babić T. Evaluacija obojenih progresivnih matrica i Chrichton ljestvice rječnika na uzorku oboljelih od Parkinsonove bolesti. Suvremena psihologija 2002; 2:295-310.
23. Bašić J, Katić S, Vranić A, Zarevski P, Babić T, Mahović-Lakušić D. Cognition in Parkinson's disease. Croatian Medical Journal 2004; 45(4): 451-6.
24. Ford MP, Malone LA, Walker HC, Nyikos I, Yelisetty R, Bickel CS. Step activity in persons with Parkinson's disease. J Phys Act Health 2010; 7:724-9.
25. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disorders 2008; 23:1428-34.
26. Jellinger K A. Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study. Acta Neuropathologica 2003; 105: 415-419.
27. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli Ch, Merino JG, Kalaria RJ, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG. Vascular cognitive impairment harmonization standards. Stroke 2006; 37: 2220-41.
28. Roman G, Sachdev P, Royall D, Bullock R, Orgogozo J, Lopez-Pousa S, Arizaga R, Wallin A. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. Journal of the Neurological Sciences 2009; 226:81-7.
29. Kulisevsky J, Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Mov Disorders 2009; 24:1103-10.
30. Boyle PA, Wilson RS, Aggarwal NT, Arvanitakis Z, Kelly J, Bienias JL, Bennett DA. Parkinsonian signs in subjects with mild cognitive impairment. Neurology 2005; 65:1901-06.
31. Jellinger KA. The neuropathologic substrate of Parkinson's disease dementia. Acta Neuropathol 2010; 119:151-3.
32. Rodrigez-Oroz MC, Jahanshahi M, Krack M, Litvan I, Macias R, Bezard E., Obeso JA. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol 2009; 8:1128-39.
33. Ebmeier KP, Calder SA, Crawford JR, Stewart L, Cochrane RHB, Besson JAO. Dementia in idiopathic Parkinson's disease: prevalence and relationship with symptoms and signs of parkinsonism. Psychol Med 1991; 21:69-76.
34. Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC. Incidence of and risk factors for cognitive impairment in an early Parkinson's disease - clinical trial cohort. Neurology 2009; 73:1469-77
35. Emre M, Aarsland D, Brown R, Burn DJ, Duykaerts Ch, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korzyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders 2007; 22:1689-707.
36. Riedel O, Klotsche J, Spottke A, Deuschl G, Forstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen HU. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from German study of epidemiology of Parkinson's disease with dementia. J Neurol 2008; 255:255-64.
37. Dubois B. et Pillon B. Cognitive deficits in Parkinson's disease. J Neurology 1996; 244:2-8.
38. Mori E. Impact of subcortical ischemic lesions on behavior and cognition. Annals of the New York Academy of Sciences 2002; 977:141-8.
39. Zijlmans JCM, Thijssen HOM, Vogels OJM, Kremer HPH, Phoels PJE, Schoonderwaldt HC, Merx JL, van Hof MA, Thien TH, Horstink MWIM. MRI in patients with suspected vascular parkinsonism. Neurology 1995; 45:2183-8.